Skip to main
AKCA
AKCA logo

Akcea Therapeutics (AKCA)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Akcea Therapeutics (AKCA) Stock

About Akcea Therapeutics (AKCA)

Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing TEGSEDI, a therapy that treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. It also offers a mature pipeline of novel drugs includi...read more
Market cap$1.85B
Today's volume
Revenue (TTM)
Avg. daily volume533.92K
EBITDA (TTM)
Open
Price / earnings ratio-46.08x
Today's range
Debt / equity
52 week range$8 - $21.71
5 year debt / equity0.52x
Beta (LTM)1.07x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsAug 4, 2020
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jun 21, 2025, the market cap for AKCA stock is $1.85B

The current P/E ratio for AKCA stock is -46.08

The 52-week high for AKCA stock is $21.71. The current AKCA stock price $undefined is 100.00% below its 52-week high

The 52-week low for AKCA stock is $8. The current AKCA stock price $undefined has increased 100.00% from its 52-week low

No, the AKCA stock does not pay dividends to its shareholders

How to buy AKCA stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in AKCA stock

    Navigate to the Explore page. Then, type AKCA into the search bar. When you see AKCA stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased AKCA stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Akcea Therapeutics Stock Earnings

The value each AKCA share was expected to gain vs. the value that each AKCA share actually gained.

Akcea Therapeutics (AKCA) reported Q2 2020 earnings per share (EPS) of -$0.49, missing estimates of -$0.35 by 40.00%. In the same quarter last year, Akcea Therapeutics's earnings per share (EPS) was $0. Akcea Therapeutics is expected to release next earnings on 08/04/2020, with an earnings per share (EPS) estimate of $0.

Buy Akcea Therapeutics (AKCA) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.